Drug Side Effects
Search
NON-SMALL CELL LUNG CANCER STAGE II
NON-SMALL CELL LUNG CANCER STAGE II
was reported 19 times
NON-SMALL CELL LUNG CANCER STAGE II is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Lipid-based Polyene Antifungal [EPC]
1
0.0001
1
Penem Antibacterial [EPC]
1
0.0000
2
Polyene Antifungal [EPC]
1
0.0000
3
Central alpha-2 Adrenergic Agonist [EPC]
1
0.0000
4
Glycopeptide Antibacterial [EPC]
1
0.0000
5
Nucleoside Analog Antiviral [EPC]
1
0.0000
6
Aminosalicylate [EPC]
1
0.0000
7
Proteasome Inhibitor [EPC]
1
0.0000
8
Fluoroquinolone Antibacterial [EPC]
1
0.0000
9
Prostacycline Vasodilator [EPC]
1
0.0000
10
Leukocyte Growth Factor [EPC]
1
0.0000
11
Folate Analog Metabolic Inhibitor [EPC]
3
0.0000
12
Loop Diuretic [EPC]
3
0.0000
13
Azole Antifungal [EPC]
1
0.0000
14
Janus Kinase Inhibitor [EPC]
1
0.0000
15
Estrogen [EPC]
1
0.0000
16
Proton Pump Inhibitor [EPC]
3
0.0000
17
Tumor Necrosis Factor Blocker [EPC]
5
0.0000
18
Corticosteroid [EPC]
6
0.0000
19
Mood Stabilizer [EPC]
1
0.0000
20
Anti-epileptic Agent [EPC]
1
0.0000
21
Thalidomide Analog [EPC]
2
0.0000
22
Platinum-based Drug [EPC]
1
0.0000
23
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
24
beta-Adrenergic Blocker [EPC]
1
0.0000
25
GLP-1 Receptor Agonist [EPC]
1
0.0000
26
Atypical Antipsychotic [EPC]
1
0.0000
27
Nonsteroidal Anti-inflammatory Drug [EPC]
2
0.0000
28
Benzodiazepine [EPC]
1
0.0000